Evolutionary Genomics Competitors and Similar CompaniesClear all

Caribou Biosciences's competitors and similar companies include Nuclera and Editas Medicine.
Caribou Biosciences
Caribou Biosciences
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
Nuclera
Nuclera
Nuclera is a company that specializes in DNA synthesis.
Editas Medicine
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Founding Date
Founding Date
2012
Founding Date
2013
Founding Date
2013
Type
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Berkeley, US HQ
Locations
Cambridge, GB HQ
Locations
Cambridge, US HQ
Boulder, US
Cambridge, US
Employees
Employees
1477% decrease
Employees
1192% decrease
Employees
20816% increase
Valuation ($)
Valuation ($)
174.4 m
Valuation ($)
N/A
Valuation ($)
256.5 m

Financial

Revenue (est.)
Revenue (est.)
$11.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$40.5m (FY, 2025)
Net income
Net income
($148.1m) (FY, 2025)
Net income
N/A
Net income
($160.1m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 159.5m
Total funding raised
$ 11.3m
Total funding raised
$ 210m
For sources of this data, please see the company profile

View Company Profiles

Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease

Nuclera is a company that specializes in DNA synthesis.

View company
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

View company